Concord Medical Services Stock Price Patterns
| CCM Stock | USD 4.06 0.31 7.09% |
Momentum 54
Impartial
Oversold | Overbought |
Wall Street Target Price 1.2 | Quarterly Revenue Growth (0.08) |
Using Concord Medical hype-based prediction, you can estimate the value of Concord Medical Services from the perspective of Concord Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Concord Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Concord because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Concord Medical after-hype prediction price | USD 4.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Concord Medical Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Concord Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Concord Medical After-Hype Price Density Analysis
As far as predicting the price of Concord Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Concord Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Concord Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Concord Medical Estimiated After-Hype Price Volatility
In the context of predicting Concord Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Concord Medical's historical news coverage. Concord Medical's after-hype downside and upside margins for the prediction period are 0.21 and 10.60, respectively. We have considered Concord Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Concord Medical is very risky at this time. Analysis and calculation of next after-hype price of Concord Medical Services is based on 3 months time horizon.
Concord Medical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Concord Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Concord Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Concord Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 6.39 | 0.15 | 0.05 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.06 | 4.21 | 3.69 |
|
Concord Medical Hype Timeline
On the 31st of January Concord Medical Services is traded for 4.06. The entity has historical hype elasticity of 0.15, and average elasticity to hype of competition of -0.05. Concord is forecasted to increase in value after the next headline, with the price projected to jump to 4.21 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 3.69%, whereas the daily expected return is currently at -0.3%. The volatility of related hype on Concord Medical is about 3780.39%, with the expected price after the next announcement by competition of 4.01. Concord Medical Services has 3.93 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Concord Medical Basic Forecasting Models to cross-verify your projections.Concord Medical Related Hype Analysis
Having access to credible news sources related to Concord Medical's direct competition is more important than ever and may enhance your ability to predict Concord Medical's future price movements. Getting to know how Concord Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Concord Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SYRA | Syra Health Corp | (0.0003) | 3 per month | 7.09 | 0.03 | 20.00 | (13.00) | 36.75 | |
| XAGE | Longevity Health Holdings | (0.13) | 10 per month | 0.00 | (0.04) | 19.23 | (20.45) | 46.80 | |
| IVF | INVO Fertility | (0.05) | 10 per month | 9.78 | 0.0004 | 17.34 | (16.50) | 218.36 | |
| SISI | Shineco | 0.15 | 6 per month | 14.83 | 0.01 | 47.37 | (36.67) | 114.83 | |
| HEPA | Hepion Pharmaceuticals | (1.33) | 13 per month | 0.00 | (0.44) | 13.95 | (25.00) | 78.13 | |
| WORX | Scworx Corp | 0.1 | 9 per month | 0.00 | (0.03) | 10.34 | (9.68) | 57.56 | |
| CELU | Celularity | 0.1 | 14 per month | 0.00 | (0.13) | 9.01 | (8.97) | 26.97 | |
| PTPI | Petros Pharmaceuticals | (0.48) | 25 per month | 0.00 | (0.09) | 15.79 | (18.18) | 55.00 | |
| BACK | IMAC Holdings | 0.01 | 23 per month | 14.45 | 0.10 | 37.80 | (25.25) | 271.43 | |
| ADTX | Aditxt Inc | (0.06) | 10 per month | 0.00 | (0.27) | 22.54 | (27.59) | 63.67 |
Concord Medical Additional Predictive Modules
Most predictive techniques to examine Concord price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Concord using various technical indicators. When you analyze Concord charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Concord Medical Predictive Indicators
The successful prediction of Concord Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Concord Medical Services, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Concord Medical based on analysis of Concord Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Concord Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Concord Medical's related companies. | 2025 | 2026 (projected) | Dividend Yield | 5.55 | 5.83 | Price To Sales Ratio | 0.0171 | 0.0163 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Concord Medical Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.39) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value—what Concord Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.